Connect with us

News

TÜV Rheinland Hong Kong launches China Compulsory Certification (CCC) services for electrical and electronic products

gbafNews28

HONG KONG SAR – Media OutReach – 12 January 2021 – In cooperation with the China Quality Certification Center (CQC), TÜV Rheinland Hong Kong has been authorized by the Certification and Accreditation Administration of the People’s Republic of China (CNCA) to provide convenient China Compulsory Certification (CCC) services for overseas clients. TÜV Rheinland’s CCC product testing scope covers information technology equipment (CNCA-C09-01) and some household and similar-use appliance (CNCA-C07-01) categories, such as electric ovens, microwave ovens, rice cookers, vacuum cleaners, electric irons, liquid heaters, skin and hair care appliances, power adapter chargers, computer built-in power supplies, display devices used in conjunction with computers, etc.

CCC is implemented by the Certification and Accreditation Administration of the People’s Republic of China (CNCA) to ensure safety for consumers in China. All products in the catalog must meet the requirements of CCC product certification Since the signing of Supplement VII to the Mainland and Hong Kong Closer Economic Partnership Arrangement (CEPA), Mainland China has been gradually opening up its CCC market to Hong Kong testing and certification bodies.

From June 1, 2020, authorized testing organizations in Hong Kong can cooperate with designated mainland certification organizations to test all products processed or manufactured in the world except China that need to apply for CCC. TÜV Rheinland Hong Kong has always been a testing laboratory accredited under the Hong Kong Laboratory Accreditation Scheme (HOKLAS), and has signed a CCC Test Authorization Agreement with the CQC. It can conduct CCC testing services for the  overseas customers.

Please click here for more information

News

Acclime establishes a strong foothold in Australia with the acquisition of CoSec Corporate Services

gbafNews28

HONG KONG, Feb. 28, 2021 /PRNewswire/ — Acclime, the premier corporate services provider in Asia, is pleased to announce that it has completed the acquisition of CoSec Corporate Services, a highly regarded firm specialising in assisting foreign clients enter and operate in Australia. With this acquisition, in addition to the presence in nine key Asian jurisdictions and a European sales office in the Netherlands, Acclime's footprint now extends into Australia, with additional sales offices in the United States of America and the United Kingdom.

Founded by Blair Lucas and Paul Dixon in 2011, CoSec offers clients entering and operating in Australia a full suite of incorporation, hosting and compliance services under one roof. The firm has extensive experience in assisting life science companies looking to conduct clinical trials in Australia and take advantage of the government's 43.5% R&D incentive program. CoSec also works with foreign companies in various industries that wish to establish a presence in the lucrative Australian market. The firm's service package covers market entry assistance, incorporation, and all ongoing accounting, payroll, and tax compliance services necessary to maintain a compliant entity.

“This is the logical next step for CoSec and presents a strategic opportunity to be part of a larger international team with established resources and networks across Acclime's established Asian portfolio,” Blair Lucas, Co-founder and Chief Executive Officer of CoSec said. “We are excited at the opportunities that lay ahead and the value we can deliver to Acclime's clients through our presence and deep understanding of the Australian, US and UK markets.”

“Each market has its own complex corporate and compliance regimes which are difficult to navigate for companies who are looking to expand into new regions,” Paul Dixon, Co-founder and Chief Financial Officer of CoSec said. “As a result of this strategic integration, our clients can benefit from a wider spectrum of professional services and gain access to regional experts to help them navigate complex emerging Asian markets.”

Australia is a trading nation and a high-growth destination for foreign investment. Twelve of its 15 largest markets are in Asia and Oceania, showing how integrated Australia's economy is with the Asian neighbours,” Martin Crawford, Co-founder and CEO of Acclime said. “With our expansion plan, having a strong footprint in Australia – an integral and desirable market in the Asia-Pacific region – is critical. CoSec fits perfectly with what we do at Acclime – assisting clients to expand and succeed in whichever Asian market they choose to enter and operate within.”

CoSec will formally transition to the Acclime brand on 1 June 2021.

About Acclime

Acclime, the premier corporate services provider in Asia, helps corporate and private clients to advance their businesses and interests in difficult-to-navigate markets in emerging Asia. The company's vision is to reinvent the corporate services sector with innovative solutions that are seamlessly delivered to the highest global standards.

For further information, please visit www.acclime.com

About CoSec

Established in 2011, CoSec has successfully managed the initial and ongoing Australian expansions for over 500 clients across a broad range of industries. Our full capabilities include company incorporation, compliance and accounting support, registered office and CFO services, and resident directors. CoSec is located in Melbourne, Sydney, Brisbane and Adelaide, with representatives based in San Francisco and London.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/acclime-establishes-a-strong-foothold-in-australia-with-the-acquisition-of-cosec-corporate-services-301237013.html

SOURCE Acclime

Continue Reading

News

Citi Plus® Official Launch Ceremony

gbafNews28

HONG KONG SAR – Media OutReach – 22 February 2021

Photo 1


Mr Lawrence Lam, Consumer Business Manager of Citibank Hong Kong, introduces saving, investment and spending services of Citi Plus® that are designed to suit needs of the younger generation.

Photo 2


Mr Lawrence Lam, Consumer Business Manager of Citibank Hong Kong, and Ms Josephine Lee, Head of Retail Bank at Citibank Hong Kong, unveil Citi Plus® at the official launch ceremony.

Photo 3



Mr Lawrence Lam, Consumer Business Manager (third from left) and Ms Josephine Lee, Head of Retail Bank of Citibank Hong Kong (forth from left), exchange wealth management tips with singer Hins Cheung (fifth from left), Jason Chan (first from left), artist Elva Ni (second from left), and athlete Cecilia Yeung (sixth from left), and talk about how Citi Plus’ features can address clients’ pain points, supporting them to achieve investment goals.

Continue Reading

News

Voluntary Announcement: IND Approval Received for A Phase III Clinical Trial of OT-101 in the United States

gbafNews28

HONG KONG SAR – Media OutReach – 22 February 2021 – This announcement is made by Ocumension Therapeutics (the “Company“, together with its subsidiaries, the “Group“) on a voluntary basis to keep the shareholders of the Company and potential investors informed of the latest business updates of the Group.

The board of directors of the Company (the “Board“) is pleased to announce that an investigational new drug (“IND“) approval for initiating a multi-regional phase III clinical trial (the “Phase III MRCT“) in the United States for OT-101, a self developed product of the Group, has been received from the United States Food and Drug Administration in February 2021. The Company plans to file IND applications with the regulatory authorities in both China and Europe Union in 2021 and initiate the Phase III MRCT of OT-101 in these regions accordingly.

OT-101 is a low-concentration atropine 0.01% eye drop developed by the Group to retard, or slow down, the progression of myopia in children and adolescents. The instability of low-concentration atropine solutions has long been a technical barrier for its commercialization. The Group developed a storage and delivery system to address low-concentration atropine solution’s instability, and also conducted several rounds of tests on the system’s reliability, closure integrity and sterility conditions.

Cautionary Statement required by Rule 18A.05 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited: The Company cannot guarantee that it will ultimately commercialize OT-101 successfully. Shareholders of the Company and potential investors are advised to exercise caution when dealing in the shares of the Company.

By order of the Board of

Ocumension Therapeutics

Dr. Lian Yong CHEN

Chairman and Executive Director

As of the date of this announcement, the Board comprises Dr. Lian Yong CHEN, Mr. Ye LIU, Dr. Zhaopeng HU and Dr. Wei LI as executive directors, Mr. Yanling CAO and Mr. Lefei SUN as non-executive directors, and Mr. Ting Yuk Anthony WU, Mr. Lianming HE, and Mr. Yiran HUANG as independent non-executive directors.


Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

Continue Reading
Editorial & Advertiser disclosureOur website provides you with information, news, press releases, Opinion and advertorials on various financial products and services. This is not to be considered as financial advice and should be considered only for information purposes. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third party websites, affiliate sales networks, and may link to our advertising partners websites. Though we are tied up with various advertising and affiliate networks, this does not affect our analysis or opinion. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you, or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish sponsored articles or links, you may consider all articles or links hosted on our site as a partner endorsed link.

Call for Entries

Global Banking and Finance Review Awards Nominations 2021
2021 Awards now open. Click Here to Nominate

Latest Posts

gbafNews28 gbafNews28
News1 hour ago

Acclime establishes a strong foothold in Australia with the acquisition of CoSec Corporate Services

HONG KONG, Feb. 28, 2021 /PRNewswire/ — Acclime, the premier corporate services provider in Asia, is pleased to announce that...

gbafNews28 gbafNews28
News1 hour ago

Appier Shares AI Predictions and Trends to Watch in 2021

TAIPEI, TAIWAN – Media OutReach – 23 February 2021 – Appier, a leading artificial intelligence (AI) company, today shares AI...

gbafNews28 gbafNews28
News1 hour ago

Hunter Fan Company Debuts Industrial Fan Line For Singapore

Inventor of Ceiling Fan Expands HVLS Product Offerings for International Market Needs   SINGAPORE – Media OutReach – 23 February...

gbafNews28 gbafNews28
News1 hour ago

Loanhere Launches New Website to Help Singaporeans Apply for Personal Loans from Licensed Money Lenders Fast and Effortlessly

SINGAPORE – Media OutReach – 23 February 2021 – Loanhere announced today the launch of its website, a one-stop destination...

gbafNews28 gbafNews28
News1 hour ago

Thrive in Abu Dhabi programme launched to encourage global talent, investors to build their futures in the emirate

Long-term visas and paths to citizenship to accelerate growth in Abu Dhabi’s priority sectors   SINGAPORE – Media OutReach –...

gbafNews28 gbafNews28
News1 hour ago

Voluntary Announcement: IND Approval Received for A Phase III Clinical Trial of OT-101 in the United States

HONG KONG SAR – Media OutReach – 22 February 2021 – This announcement is made by Ocumension Therapeutics (the “Company“,...

gbafNews28 gbafNews28
News1 hour ago

Citi Plus® Official Launch Ceremony

HONG KONG SAR – Media OutReach – 22 February 2021 Photo 1 Mr Lawrence Lam, Consumer Business Manager of Citibank...

gbafNews28 gbafNews28
News1 hour ago

Hong Kong Productivity Council and Hong Kong Computer Society Sign Pact to Enhance the Adoption of Emerging Technologies in Hong Kong

HONG KONG SAR – Media OutReach – 22 February 2021 – The Hong Kong Productivity Council (HKPC) and the Hong...

gbafNews28 gbafNews28
News1 hour ago

Citibank Officially Launches Citi Plus®

Co-creating With Target Clients to Suit Their Banking and Investment Needs Fostering Financial Education to Level-Up Digital Natives Through Mobile...

gbafNews28 gbafNews28
News1 hour ago

Kerry Logistics Network Extends Winning Streak at the Quamnet Outstanding Enterprise Awards for Sixth Year Running

HONG KONG SAR – Media OutReach – 22 February 2021 – Kerry Logistics Network Limited (‘Kerry Logistics Network’; Stock Code...